The study aimed to determine the relationships between the basal metabolic rate（BMR） and body composition of overweight and obese Chinese adults with type 2 diabetes mellitus（DM）. This cross-sectional clinical stu...The study aimed to determine the relationships between the basal metabolic rate（BMR） and body composition of overweight and obese Chinese adults with type 2 diabetes mellitus（DM）. This cross-sectional clinical study enrolled 193 Chinese adults with type 2 DM who were overweight（24 kg/m2≤BMI〈28 kg/m2, n=99）, or obese（BMI ≥28 kg/m2, n=94）. Ninety-seven adults with normal BMIs, including 50 DM patients and 47 healthy adults, were recruited as a control group. BMR was measured by indirect calorimetry; predicted BMR was calculated according to the Schofield equation; and the relationships between BMR, body composition, and biochemical results were determined by the Pearson correlation. The results showed that obese DM patients had significantly higher BMRs than both overweight patients（P〈0.05） and patients with normal BMI did（P〈0.05）. The measured BMR was significantly lower than the predicted BMR（P〈0.05） in all groups. Obese and overweight DM patients had significantly greater weight, waist circumference, hip circumference, BMI, body surface area, body fat percentage, fat mass, and fat-free mass than patients with normal BMI. Except for waist circumference, these body composition measurements were significantly increased in obese DM patients when compared with those in overweight DM patients（P〈0.05）. Fat-free mass was closely correlated with BMR in both DM patients（r=0.874, P〈0.01） and in healthy controls（r=0.902, P〈0.01）. It was concluded that overweight and obese Chinese adults with type 2 DM had increased BMRs compared with normal-weight controls, which may result from the difference in fat-free mass.展开更多
目的评价度拉糖肽联合卡格列净对早期血糖控制不佳超重型2型糖尿病(T2DM)患者的临床治疗效果。方法研究对象为2021年7月至2022年12月在郑州人民医院内分泌代谢科收治的口服联合降糖方案血糖控制不好的超重型T2DM患者120例,随机分为试验...目的评价度拉糖肽联合卡格列净对早期血糖控制不佳超重型2型糖尿病(T2DM)患者的临床治疗效果。方法研究对象为2021年7月至2022年12月在郑州人民医院内分泌代谢科收治的口服联合降糖方案血糖控制不好的超重型T2DM患者120例,随机分为试验组和对照组,每组60例。试验组以周制剂度拉糖肽联合卡格列净治疗,对照组给予14 d胰岛素泵治疗至血糖稳定后,改用门冬胰岛素30注射液。经3个月治疗后,比较两种不同治疗策略的临床效果。包括临床疗效、血糖情况、胰岛功能、体格检查指标、血脂情况、血清因子[中性粒细胞与淋巴细胞比值(NLR)、C反应蛋白(CRP)、谷胱甘肽过氧化物酶(GSH-Px)及超氧化物歧化酶(SOD)]水平比较,分析GSH-Px、SOD分别与NLR及CRP间的相关性;并对比其诊疗过程中发生的不良反应。结果共剔除患者16例,最终纳入统计学分析病例包括试验组52例,对照组52例。两组空腹血糖(FPG)、餐后2 h血糖(2 h PG)及糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、NLR及CRP水平与治疗前相比均降低,空腹胰岛素(FINS)、稳态模型胰岛β细胞功能指数(HOMA-β)、空腹C肽(FCP)、高密度脂蛋白(HDL-C)、GSH-Px及SOD水平与治疗前相比均增加,且试验组优于对照组,差异有统计学意义(P<0.05)。Pearson分析可知,GSH-Px与NLR、CRP及NLR与SOD均呈负相关。治疗过程中,试验组不良反应发生率为19.23%(10/52),对照组为36.54%(19/52),试验组低于对照组,差异有统计学意义(χ^(2)=3.873,P<0.05)。结论度拉糖肽联合卡格列净对于早期血糖控制不佳超重型T2DM患者较胰岛素表现出更好的临床治疗效果,值得临床推广应用。展开更多
基金supported by the National Natural Science Foundation of China(No.81370942)
文摘The study aimed to determine the relationships between the basal metabolic rate（BMR） and body composition of overweight and obese Chinese adults with type 2 diabetes mellitus（DM）. This cross-sectional clinical study enrolled 193 Chinese adults with type 2 DM who were overweight（24 kg/m2≤BMI〈28 kg/m2, n=99）, or obese（BMI ≥28 kg/m2, n=94）. Ninety-seven adults with normal BMIs, including 50 DM patients and 47 healthy adults, were recruited as a control group. BMR was measured by indirect calorimetry; predicted BMR was calculated according to the Schofield equation; and the relationships between BMR, body composition, and biochemical results were determined by the Pearson correlation. The results showed that obese DM patients had significantly higher BMRs than both overweight patients（P〈0.05） and patients with normal BMI did（P〈0.05）. The measured BMR was significantly lower than the predicted BMR（P〈0.05） in all groups. Obese and overweight DM patients had significantly greater weight, waist circumference, hip circumference, BMI, body surface area, body fat percentage, fat mass, and fat-free mass than patients with normal BMI. Except for waist circumference, these body composition measurements were significantly increased in obese DM patients when compared with those in overweight DM patients（P〈0.05）. Fat-free mass was closely correlated with BMR in both DM patients（r=0.874, P〈0.01） and in healthy controls（r=0.902, P〈0.01）. It was concluded that overweight and obese Chinese adults with type 2 DM had increased BMRs compared with normal-weight controls, which may result from the difference in fat-free mass.
文摘目的评价度拉糖肽联合卡格列净对早期血糖控制不佳超重型2型糖尿病(T2DM)患者的临床治疗效果。方法研究对象为2021年7月至2022年12月在郑州人民医院内分泌代谢科收治的口服联合降糖方案血糖控制不好的超重型T2DM患者120例,随机分为试验组和对照组,每组60例。试验组以周制剂度拉糖肽联合卡格列净治疗,对照组给予14 d胰岛素泵治疗至血糖稳定后,改用门冬胰岛素30注射液。经3个月治疗后,比较两种不同治疗策略的临床效果。包括临床疗效、血糖情况、胰岛功能、体格检查指标、血脂情况、血清因子[中性粒细胞与淋巴细胞比值(NLR)、C反应蛋白(CRP)、谷胱甘肽过氧化物酶(GSH-Px)及超氧化物歧化酶(SOD)]水平比较,分析GSH-Px、SOD分别与NLR及CRP间的相关性;并对比其诊疗过程中发生的不良反应。结果共剔除患者16例,最终纳入统计学分析病例包括试验组52例,对照组52例。两组空腹血糖(FPG)、餐后2 h血糖(2 h PG)及糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、NLR及CRP水平与治疗前相比均降低,空腹胰岛素(FINS)、稳态模型胰岛β细胞功能指数(HOMA-β)、空腹C肽(FCP)、高密度脂蛋白(HDL-C)、GSH-Px及SOD水平与治疗前相比均增加,且试验组优于对照组,差异有统计学意义(P<0.05)。Pearson分析可知,GSH-Px与NLR、CRP及NLR与SOD均呈负相关。治疗过程中,试验组不良反应发生率为19.23%(10/52),对照组为36.54%(19/52),试验组低于对照组,差异有统计学意义(χ^(2)=3.873,P<0.05)。结论度拉糖肽联合卡格列净对于早期血糖控制不佳超重型T2DM患者较胰岛素表现出更好的临床治疗效果,值得临床推广应用。
